EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES : revenue, balance sheet and financial ratios

EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES is a French company founded 6 years ago, specialized in the sector Analyses, essais et inspections techniques. Based in VENISSIEUX (69200), this company of category GE shows in 2024 a revenue of 1.6 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES (SIREN 880107727)
Indicator 2024 2023 2022 2021 2020 2019
Revenue 1 617 169 € 5 304 € N/C N/C N/C N/C
Net income -875 387 € -749 719 € -354 129 € -70 947 € -16 285 € -7 500 €
EBITDA -883 349 € -846 017 € -473 895 € -70 646 € -16 285 € -7 500 €
Net margin -54.1% -14135.0% N/C N/C N/C N/C

Revenue and income statement

In 2024, EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES achieves revenue of 1.6 M€. Over the period 2023-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +30389.6%. Vs 2023, growth of +30390% (5 k€ -> 1.6 M€). After deducting consumption (223 k€), gross margin stands at 1.4 M€, i.e. a rate of 86%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -883 k€, representing -54.6% of revenue. Positive scissor effect: EBITDA margin improves by +15895.9 pts, sign of improved operational efficiency. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -875 k€ (-54.1% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

1 617 169 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

1 393 792 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-883 349 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-875 513 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-875 387 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-54.4%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 5%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

4.583%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

77.612%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-54.424%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-0.128

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

83.5%

Solvency indicators evolution
EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES

Sector positioning

Debt ratio
4.58 2024
2022
2023
2024
Q1: 0.0
Med: 9.99
Q3: 48.5
Good -39 pts over 3 years

In 2024, the debt ratio of EUROFINS LABORATOIRE MICR... (4.58) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
77.61% 2024
2022
2023
2024
Q1: 11.63%
Med: 34.78%
Q3: 58.76%
Excellent +48 pts over 3 years

In 2024, the financial autonomy of EUROFINS LABORATOIRE MICR... (77.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
-0.13 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.87 years
Excellent

In 2024, the repayment capacity of EUROFINS LABORATOIRE MICR... (-0.13) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 156.89. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

156.886

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-0.637

Liquidity indicators evolution
EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES

Sector positioning

Liquidity ratio
156.89 2024
2022
2023
2024
Q1: 133.14
Med: 205.95
Q3: 337.03
Average +8 pts over 3 years

In 2024, the liquidity ratio of EUROFINS LABORATOIRE MICR... (156.89) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-0.64x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.02x
Q3: 2.48x
Average

In 2024, the interest coverage of EUROFINS LABORATOIRE MICR... (-0.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 105 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 46 days. The gap of 59 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 12 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 109 days of revenue, i.e. 489 k€ to permanently finance.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

489 372 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

105 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

46 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

12 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

109 j

WCR and payment terms evolution
EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES

Positioning of EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES in its sector

Comparison with sector Analyses, essais et inspections techniques

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (41 transactions). This range of 144 610€ to 1 145 859€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2024
Indicative
144k€ 700k€ 1145k€
700 928 € Range: 144 610€ - 1 145 859€
NAF 5 année 2024

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 41 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Analyses, essais et inspections techniques)

Compare EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES with other companies in the same sector:

Voir toutes les statistiques du secteur Analyses, essais et inspections techniques

Frequently asked questions about EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES

What is the revenue of EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES ?

The revenue of EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES in 2024 is 1.6 M€.

Is EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES profitable?

EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES recorded a net loss in 2024.

Where is the headquarters of EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES ?

The headquarters of EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES is located in VENISSIEUX (69200), in the department Rhone.

Where to find the tax return of EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES ?

The tax return of EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES operate?

EUROFINS LABORATOIRE MICROBIOLOGIE RHONE-ALPES operates in the sector Analyses, essais et inspections techniques (NAF code 71.20B). See the 'Sector positioning' section above to compare the company with its competitors.